April 30, 2015
Please join us at our special tenth annual World IP Day event as we explore emerging issues in intellectual property, including patent reform, the new role of the record label in the digital music era, and the increasing importance of IP to U.S. trade issues.
The cost of developing new prescription drugs is very expensive—a process made even more expensive than it has to be because of excessive government restrictions and limited patent life. However, not developing new drugs can also be expensive, both in financial and human costs.
A bill working through the Texas Legislature, HB 40, is a positive step toward making sure that rule of law, not majority tyranny, governs municipal rule-making. Tom Giovanetti discusses with 660 AM The Answer’s Mark Davis.